Loading...

Aaron Rosenberg

Title(s)Assistant Professor, Hematology and Oncology
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Rosenberg AS, Brunson A, Jonas BA, Keegan THM, Wun T. Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma. J Natl Cancer Inst. 2019 Jan 01; 111(1):78-85. PMID: 29897481.
      View in: PubMed
    2. Pon TK, Mahajan A, Rosenberg A, Amin A, Shah D, Jenkins I, Gupta V, Hofmann H, Bejjani A, White R. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2018 May; 45(4):536-542. PMID: 29574610.
      View in: PubMed
    3. Gupta S, Abouzaid S, Liebert R, Parikh K, Ung B, Rosenberg AS. Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2018 03; 18(3):210-218. PMID: 29429817.
      View in: PubMed
    4. Keegan THM, Bleyer A, Rosenberg AS, Li Q, Goldfarb M. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors. JAMA Oncol. 2017 Nov 01; 3(11):1554-1557. PMID: 28426850.
      View in: PubMed
    5. Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM, Jonas BA. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J. 2017 09 08; 7(9):e605. PMID: 28885611.
      View in: PubMed
    6. Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. Br J Haematol. 2017 07; 178(1):72-80. PMID: 28542862.
      View in: PubMed
    7. Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Br J Haematol. 2017 07; 178(2):319-326. PMID: 28369826.
      View in: PubMed
    8. Rosenberg AS, Ruthazer R, Paulus JK, Kent DM, Evens AM, Klein AK. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders. Clin Lymphoma Myeloma Leuk. 2016 12; 16(12):684-692.e3. PMID: 27771291.
      View in: PubMed
    9. Rosenberg AS, Bainbridge S, Pahwa R, Jialal I. Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay. Clin Biochem. 2016 Oct; 49(15):1202-1204. PMID: 27475249.
      View in: PubMed
    10. Rosenberg AS, Klein AK, Ruthazer R, Evens AM. Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival. Am J Hematol. 2016 06; 91(6):560-5. PMID: 26928381.
      View in: PubMed
    11. Paulus JK, Rosenberg AS. Breast cancer and thrombosis: timing matters. Blood. 2016 Feb 18; 127(7):793-4. PMID: 26893393.
      View in: PubMed
    12. Shah GL, Rosenberg AS, Jarboe J, Klein A, Cossor F. Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging. ScientificWorldJournal. 2014; 2014:380814. PMID: 25374938.
      View in: PubMed
    13. Rosenberg A, Mathew P. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor. Expert Opin Investig Drugs. 2013 Jun; 22(6):787-94. PMID: 23540855.
      View in: PubMed